ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 78 filers reported holding ATHIRA PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,430,875 | -31.5% | 1,698,453 | 0.0% | 0.00% | – |
| Q2 2023 | $5,010,436 | +8.8% | 1,698,453 | -7.8% | 0.00% | – |
| Q1 2023 | $4,606,613 | -20.9% | 1,842,645 | +0.3% | 0.00% | – |
| Q4 2022 | $5,826,248 | +7.1% | 1,837,933 | +0.3% | 0.00% | – |
| Q3 2022 | $5,441,000 | +10.8% | 1,832,030 | +13.7% | 0.00% | – |
| Q2 2022 | $4,912,000 | -75.9% | 1,610,580 | +6.6% | 0.00% | – |
| Q1 2022 | $20,400,000 | +2.0% | 1,511,078 | -1.6% | 0.00% | – |
| Q4 2021 | $20,005,000 | +29.9% | 1,535,241 | -6.5% | 0.00% | – |
| Q3 2021 | $15,397,000 | +9.9% | 1,641,483 | +20.0% | 0.00% | – |
| Q2 2021 | $14,004,000 | -2.4% | 1,367,599 | +75.5% | 0.00% | – |
| Q1 2021 | $14,342,000 | -35.2% | 779,468 | +20.6% | 0.00% | -100.0% |
| Q4 2020 | $22,131,000 | +1098.2% | 646,165 | +546.2% | 0.00% | – |
| Q3 2020 | $1,847,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |